We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Researchers Construct Computer Simulations of Laser-Nanoparticle Treatments

By LabMedica International staff writers
Posted on 16 Jun 2009
Two lasers may be better than one when attacking cancer cells, according to a recent report.

Dr. More...
Yildiz Bayazitoglu, a professor of mechanical engineering from Rice University (Houston, TX, USA) and a specialist on heat transfer and fluid flow, and doctoral student Jerry Vera are using computer simulations to quantify the effect of heating nanoparticles with near-infrared lasers to destroy cancer tumors without damaging healthy tissue.

The investigators hope to increase the effectiveness of destroying tumors by modifying methods of heating them based on the size and composition of not only the tumor but also the surrounding tissue. The study was published in the January 2009 issue of the International Journal of Heat and Mass Transfer.

The researchers revealed that attacking a tumor with two lasers could heat it more thoroughly than a single laser. For tumors as large as 1 cm, simulations showed opposing lasers surgically inserted via fiberoptics in a minimally invasive procedure generated the most uniform temperature profile in every case.

Lasers and nanoparticles are already being used to treat cancer. A company founded by Rice scientists Drs. Jennifer West and Naomi Halas, Nanospectra Biosciences, Inc. (Houston, TX, USA), is conducting human tests of a system that uses nanoshells heated by near-infrared lasers to kill tumors. Drs. Bayazitoglu, West, and Halas are all part of Rice's Laboratory for Nanophotonics.

The Bayazitoglu group's approach would refine such treatment by taking into account the light-scattering properties of nanoparticles. Their concern is that nanoparticles near the surface of a tumor will block a laser from reaching those at the center. "Think about it this way: If you're driving on a very foggy night, you can only see just so far no matter how good your headlights are,” commented Dr. Vera. "That's because the millions of small water droplets in the air absorb and scatter the light, deflecting the beams from your headlights before they can reflect off of whatever's ahead of you on the road. Nanoparticles dispersed within a tumor do exactly the same thing. They're very good at absorbing laser light and generating heat, but within particularly thick tumors, that same quality prevents a lot of the light from reaching deeper into the tissue.”

Dr. Bayazitoglu reported that this phenomenon, called "extinction,” is "highly undesirable.” A uniform temperature profile of at least 60 oC has to be created to kill the whole tumor. "Raising the temperature on one end but not the other will simply allow the tumor to regrow, and that doesn't solve the problem--or cure the patient.”

The density and placement of nanoparticles in the tumor are critical, according to Dr. Bayazitoglu. "Ideally, you should put nanoparticles at the center of the tumor, then kill it from the center out,” Dr. Bayazitoglu said.

Laser treatment may be effective even if nanoparticles are not used, she noted. "If the tumor has good absorption properties, slow heating can do a good job of killing the cancer, because the heat has time to get inside. If you're doing that, sometimes it's better not to use nanoparticles.”

With so many tissue types and the great range of cancers people face, the importance of accurate simulations cannot be overemphasized, according to the researchers. They hope the ability to calculate scenarios will allow clinicians to find the best laser therapy to produce the perfect heating environment.

Related Links:

Rice University
Nanospectra Biosciences


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.